Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Non Operating Income (2022 - 2026)

Updated

Avenue Therapeutics (ATXI) posted Non Operating Income of $17,000 for Q2 2026, down 46.9% from $32,000 a year earlier and down 10.5% from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Non Operating Income (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Avenue Therapeutics was $100,000, down 63.0% year-over-year.

  • The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 387.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Mar 31, 2026 19,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 32,000.00
Mar 31, 2025 47,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 122,000.00
Mar 31, 2024 -641,000.00
Sep 30, 2023 2.58 Mn
Jun 30, 2023 -93,000.00
Mar 31, 2023 -1.17 Mn
Sep 30, 2022 1,000.00
Jun 30, 2022 1,000.00
Mar 31, 2022 2,000.00
API Access

Avenue Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATXI&period=max&api_key=YOUR_API_KEY